Takeda Pharmaceutical Company Limited: updates and filings

TAKNYSEHealthcare · Pharmaceutical Preparations

Price

$21.93

November 20, 2026

What Ploutos Investor adds for Takeda Pharmaceutical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 10 fiscal years, from FY2017
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Jun 17, 2026 latest annual
  • Oct 29, 2026Current report (foreign company)
    Form6-K
  • Oct 29, 2026Current report (foreign company)
    Form6-K
  • Sep 14, 2026Current report (foreign company)
    Form6-K
  • Aug 31, 2026Current report (foreign company)
    Form6-K
  • Aug 6, 2026Current report (foreign company)
    Form6-K
  • Jul 30, 2026Current report (foreign company)
    Form6-K
  • Jul 9, 2026Current report (foreign company)
    Form6-K
  • Jul 8, 2026Current report (foreign company)
    Form6-K
  • Jun 29, 2026Current report (foreign company)
    Form6-K
  • Jun 26, 2026Current report (foreign company)
    Form6-K
  • Jun 24, 2026Current report (foreign company)
    Form6-K
  • Jun 24, 2026Current report (foreign company)
    Form6-K
  • Jun 24, 2026Current report (foreign company)
    Form6-K
  • Jun 17, 2026Filing
    FormIRANNOTICE
  • Jun 17, 2026Annual report (foreign company)for the period to Mar 31, 2026
    Form20-F
  • Jun 9, 2026Current report (foreign company)
    Form6-K
  • Jun 5, 2026Current report (foreign company)
    Form6-K
  • Jun 5, 2026Current report (foreign company)
    Form6-K
  • Jun 1, 2026Current report (foreign company)
    Form6-K
  • May 26, 2026Current report (foreign company)
    Form6-K
  • May 26, 2026Current report (foreign company)
    Form6-K
  • May 26, 2026Current report (foreign company)
    Form6-K
  • May 26, 2026Current report (foreign company)
    Form6-K
  • May 26, 2026Current report (foreign company)
    Form6-K
  • May 22, 2026Conflict minerals report
    FormSD

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Mar 5, 2007.

The full analysis

What do Takeda Pharmaceutical's filings show?

The filings are where every one of Takeda Pharmaceutical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.